ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC.

Tian, Yaru; Zhai, Xiaoyang; Yan, Weiwei; Zhu, Hui; Yu, Jinming
Cancer Med2021-1DOI: 10.1002/cam4.3590
7阅读
引用收藏
分享

摘要

Immune checkpoint blockades (ICBs) have changed the standard of care of squamous and adenocarcinoma non-small cell lung cancer (NSCLC). Whereas detailed researches regarding ICBs in the two major histological subtypes are rare. In order to uncover the clinical efficacy differences between squamous and adenocarcinoma NSCLC and better understand the underlying immune-regulatory mechanisms, we compared the survival benefits of ICBs between the two subtypes by revealing phase 3 randomized trials and attempted to uncover the immune-regulatory discrepancy. Generally, compared with nonsquamous NSCLC, squamous NSCLC benefited more from ICBs in Keynote 024, CheckMate 026, CheckMate 227 and CheckMate 017 and similar in OAK, but less in Keynote 010 and PACIFIC. We revealed that the tumor mutation burden (TMB) level, the programmed cell death ligand 1 (PD-L1) expression, tumor infiltrating lymphocytes (TILs) in the tumor microenvironment (TME), chemokines, and oncogenic driver alterations within the two subtypes may contributed to the clinical outcomes of ICBs. We prospected that the combinations of ICBs with chemotherapy, radiation therapy, and antiangiogenic therapy could be promising strategies to re-immunize the less immunogenic tumors and further enhance the efficacy of ICBs.

学科与关键词

关键词
adenocarcinoma NSCLCimmune checkpoint blockadesimmune escape mechanismssquamous NSCLC
相关
加载中…
  • Effects on immunotherapy of EGFR mutation subtypes in non-squamous NSCLC.
    Tang, Haibo; Li, Xiaoning; Xie, Wenzhuan; Huang, MengliAnnual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, 2021-04-10 To 2021.
  • Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art
    Kang, Jin; Zhang, Chao; Zhong, Wen-Zhao*Cancer Communications, 2021, 41(4): 287-302.被引 62
  • The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Sun, Yueqin; Yang, Qi; Shen, Jie; Wei, Ting; Shen, Weitao; Zhang, Nan; Luo, Peng*; Zhang, Jian*Frontiers in Cell and Developmental Biology, 2021, 09: 745859.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Med
发表日期
2021-01
卷期
第 10 卷, 第 1 期
页码
3-14
DOI
10.1002/cam4.3590
成果收录
PUBMED

作者

  • T

    Tian, Yaru (第一作者)

  • Z

    Zhai, Xiaoyang

查看全部 5 位作者收起作者
  • Y

    Yan, Weiwei

  • Z

    Zhu, Hui

  • Y

    Yu, Jinming

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417